| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.804 | 20.903 | 14.302 | 22.577 | 23.100 | 16.431 | 21.788 | 33.241 | 11.750 | 2.112 |
| Total Income - EUR | 7.804 | 20.903 | 14.302 | 22.577 | 23.100 | 16.674 | 21.788 | 33.241 | 11.750 | 2.112 |
| Total Expenses - EUR | 9.498 | 24.172 | 19.479 | 28.668 | 29.388 | 19.967 | 22.726 | 31.756 | 14.829 | -61 |
| Gross Profit/Loss - EUR | -1.694 | -3.269 | -5.177 | -6.091 | -6.288 | -3.292 | -938 | 1.485 | -3.080 | 2.172 |
| Net Profit/Loss - EUR | -1.928 | -3.687 | -5.322 | -6.317 | -6.519 | -3.784 | -1.592 | 488 | -3.105 | 2.172 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Nicofermi Plus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 102 | 534 | 433 | 336 | 241 | 151 | 63 | 0 | 0 | 0 |
| Current Assets | 669 | 8.464 | 8.441 | 6.169 | 9.277 | 4.162 | 9.374 | 7.098 | 2.307 | 188 |
| Inventories | 517 | 7.167 | 6.980 | 3.741 | 3.008 | 365 | 1.959 | 3.489 | 1.976 | 0 |
| Receivables | 0 | 968 | 1.036 | 1.821 | 3.792 | 3.673 | 4.715 | 3.199 | 46 | 79 |
| Cash | 152 | 329 | 425 | 606 | 2.477 | 124 | 2.700 | 410 | 285 | 109 |
| Shareholders Funds | -1.883 | -5.551 | -10.779 | -16.898 | -23.090 | -26.436 | -27.442 | -27.039 | -30.062 | -27.722 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.654 | 14.548 | 19.653 | 23.403 | 32.608 | 30.748 | 36.879 | 34.137 | 32.370 | 27.910 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4799 - 4799" | |||||||||
| CAEN Financial Year |
4332
|
|||||||||
Comments - Nicofermi Plus Srl